Abstract:Altered levels of steroids have been reported in the brain, cerebral spinal fluid and plasma of patients with mood disorders. Neuroimaging studies have reported both functional and structural alterations in mood disorders, for instance in the anterior cingulate cortex (ACC) and dorsolateral prefrontal cortex (DLPFC). In order to determine whether the endogenous production of steroids is altered in the ACC and DLPFC of patients with major depressive disorder (MDD) or bipolar disorder (BPD), quantitative real-time PCR was performed to detect mRNA expression level of key enzymes in the steroid biosynthetic pathways. In MDD, a significant decrease in mRNA level of cytochrome P450 17A1 (CYP17A1, synthesizing C19 ketosteroids) in the ACC and a significant increase in mRNA levels of hydroxysteroid sulfotransferase 2A1 [SULT2A1, catalyzing the sulfate conjugation of dehydroepiandrosterone (DHEA)] were observed in the DLPFC, suggesting alterations in DHEA and its sulfate metabolite DHEAS levels. Decreased intensity and distribution of CYP17A1 immunohistochemical staining was found in the ACC of MDD patients. Interestingly, there was a significant positive correlation between the mRNA levels of CYP17A1 and tyrosine-related kinase B (TrkB) full length isoform. In a unique post-mortem human brain slice culture paradigm, BDNF mRNA expression was found to be significantly increased following incubation with DHEA. Together, these data indicate a close relationship between DHEA and BDNF-TrkB pathways in depression. Furthermore, in the DLPFC, higher mRNA levels of 11 beta-hydroxysteroid dehydrogenase-1 (HSD11B1, reducing cortisone to the active hormone cortisol) and steroidogenic acute regulatory protein (STAR, facilitating the shuttle of cholesterol through the intermembrane space) were found in the MDD patients and BPD patients, respectively. In conclusion, this study suggests the presence of a disturbance in the endogenous synthesis of DHEA and DHEAS in mood disorders, which has a close relationship with BDNF-TrkB signaling.

Clinical significance of decreased protein expression of dehydroepiandrosterone sulfate in the development of depression: a meta-analysis.

Aromatase Changes in Depression: A Postmortem and Animal Experimental Study.

Association of Endogenous DHEA/DHEAS with Coronary Heart Disease: A Systematic Review and Meta-Analysis.

Alterations in the steroid biosynthetic pathways in the human prefrontal cortex in mood disorders: a postmortem study.

Prognostic Value of Dehydroepiandrosterone Sulfate for Patients with Cardiovascular Disease: A Systematic Review and Meta‐Analysis

Anthropometric and Biochemical Assessment of the Nutritional State in Depression: Evidence for Lower Visceral Protein Plasma Levels in Depression

Analyses of vitamin D2/D3 levels in moderately and severely depressive patients

Association among Serum Cortisol, Dehydroepiandrosterone-Sulfate Levels and Psychiatric Symptoms in Men with Chronic Schizophrenia

Total Serum-Protein and Serum-Protein Fractions in Depression - Relationships to Depressive Symptoms and Glucocorticoid Activity

The effect of vitamin D supplementation on primary depression: A meta-analysis

Depression-Like Behavior in a Dehydroepiandrosterone-Induced Mouse Model of Polycystic Ovary Syndrome

An Analysis of Plasma Reveals Proteins in the Acute Phase Response Pathway to Be Candidate Diagnostic Biomarkers for Depression

The 25(OH)D/VDR Signaling May Play a Role in Major Depression

Efficacy of vitamin D supplementation on depressive symptoms in older patients: a meta-analysis of randomized controlled trials

Peripheral Cytokine and Chemokine Alterations in Depression: a Meta-Analysis of 82 Studies.

Elevated C-Reactive Protein and Erythrocyte Sedimentation Rate Correlates with Depression in Psoriasis: A Chinese Cross-Sectional Study

DHEA and response to antidepressant treatment: A Mendelian Randomization analysis

Aberrant Stress Hormone Receptor Balance in the Human Prefrontal Cortex and Hypothalamic Paraventricular Nucleus of Depressed Patients.

Altered Circulating GDF-15 Level Predicts Sex Hormone Imbalance in Males with Major Depressive Disorder

Decreased serum dipeptidyl peptidase IV activity in major depression.